Cadernos de Saúde Pública (Jan 2016)

Lobbying by Big Pharma, bottlenecks for clinical research, and loosening of ethical standards in Brazil

  • Francisco José Roma Paumgartten

DOI
https://doi.org/10.1590/0102-311x00189815
Journal volume & issue
Vol. 32, no. 2

Abstract

Read online

No abstracts available.